Federated Hermes’s Kite Pharma, Inc. KITE Stock Holding History

Federated Hermes’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-24,460	Closed	-$2.54M	–	2241
2017 Q2	$2.54M	Buy	+24,460	New	+$2M	0.01%	809
2017 Q1	–	Sell	-10,000	Closed	-$448K	–	2235
2016 Q4	$448K	Hold	10,000	–	–	﹤0.01%	1339
2016 Q3	$559K	Sell	10,000 -2,000	-17%	-$111K	﹤0.01%	1253
2016 Q2	$600K	Buy	+12,000	New	+$590K	﹤0.01%	1227
2015 Q4	–	Sell	-20,000	Closed	-$1.11M	–	2206
2015 Q3	$1.11M	Hold	20,000	–	–	﹤0.01%	1066
2015 Q2	$1.22M	Buy	20,000 +5,000	+33%	+$285K	﹤0.01%	1090
2015 Q1	$865K	Hold	15,000	–	–	﹤0.01%	1220
2014 Q4	$865K	Sell	15,000 -15,000	-50%	-$632K	﹤0.01%	1226
2014 Q3	$855K	Buy	+30,000	New	+$742K	﹤0.01%	1233

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes's KITE Position: Q3 2017 in Review

Federated Hermes sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 24,460 shares — an estimated $2.54M sold.

Federated Hermes first reported a position in KITE in Q3 2014 and held it in 9 quarters. The position peaked at $2.54M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Federated Hermes reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Federated Hermes sold 24,460 Kite Pharma, Inc. shares in Q3 2017, an estimated $2.54M.
Federated Hermes first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 9 quarters.
Federated Hermes's Kite Pharma, Inc. position peaked at $2.54M in Q2 2017.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Federated Hermes's 13F filing for Q3 2017, filed 13 Nov 2017.